Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.51 -0.01 (-0.22%) Market Cap: 720.42 Mil Enterprise Value: 1.26 Bil PE Ratio: 112.75 PB Ratio: 0 GF Score: 55/100

Q1 2019 Ironwood Pharmaceuticals Inc Earnings Call Transcript

May 02, 2019 / 12:30PM GMT
Release Date Price: $10.27 (-12.82%)
Operator

Good morning. My name is James, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Ironwood Pharmaceutical First Quarter 2019 Investor Update Call. (Operator Instructions)

And now I would like to turn the call over to your host, Meredith Kaya. Please go ahead.

Meredith Kaya
Ironwood Pharmaceuticals, Inc. - VP of IR & Corporate Communications

Good morning, and thanks you for joining us for our first quarter 2019 investor update. Our press release crossed the wire earlier this morning and can be found on our website, www.ironwoodpharma.com.

Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current Safe Harbor Statement slide as well as under the heading Risk Factors in our annual report on Form 10-K for the year ended December 31, 2018,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot